A Six Month Safety Follow-up Study in Subjects with Eosinophilic Esophagitis (EoE) who Completed Study PR-021 [PR-021: A multicenter randomized double-blind placebo-controlled safety and tolerability phase 1/2a study of two dosing regimens of EUR
-
- STATUS
- Not Recruiting
Updated on 19 February 2024
Summary
The focus of this 6 month safety follow-up (Study PR-022) to Study PR-021 will be on glucocorticosteroids-related adverse events and HPA axis suppression.
Description
The focus of this 6 month safety follow-up (Study PR-022) to Study PR-021 will be on glucocorticosteroids-related adverse events and HPA axis suppression.
Details
| Condition | Eosinophilic Esophagitis |
|---|---|
| Age | 100years or below |
| Clinical Study Identifier | TX2621 |
| Last Modified on | 19 February 2024 |
How understandable was the trial content above?
Hard to understand
Easy to understand
Similar trials to consider
Loading...
Not finding what you're looking for?
Sign up as a volunteer to stay informed
Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.
Sign up as volunteerStudy Definition
WikipediaAdd a private note
- Select a piece of text.
- Add notes visible only to you.
- Send it to people through a passcode protected link.